| Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring R Tyzio, R Nardou, DC Ferrari, T Tsintsadze, A Shahrokhi, S Eftekhari, ... Science 343 (6171), 675-679, 2014 | 627 | 2014 |
| Bumetanide reduces seizure frequency in patients with temporal lobe epilepsy S Eftekhari, J Mehvari Habibabadi, M Najafi Ziarani, ... Epilepsia 54 (1), e9-e12, 2013 | 106 | 2013 |
| GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease N Lozovaya, S Eftekhari, R Cloarec, LA Gouty-Colomer, A Dufour, ... Nature Communications 9 (1), 1422, 2018 | 97 | 2018 |
| Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth N Lozovaya, R Nardou, R Tyzio, M Chiesa, A Pons-Bennaceur, ... Scientific reports 9 (1), 9276, 2019 | 56 | 2019 |
| The most important metabolic risk factors in recurrent urinary stone formers M Parvin, N Shakhssalim, A Basiri, AH Miladipour, B Golestan, PM Torbati, ... Urology journal 8 (2), 99-106, 2011 | 54 | 2011 |
| BDNF modifies hippocampal KCC2 and NKCC1 expression in a temporal lobe epilepsy model S Eftekhari, S Mehrabi, M Soleimani, G Hassanzadeh, A Shahrokhi, ... Acta neurobiologiae experimentalis 74 (3), 276-287, 2014 | 40 | 2014 |
| Response to Comment on “Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring” S Eftekhari, A Shahrokhi, V Tsintsadze, R Nardou, C Brouchoud, ... Science 346 (6206), 176-176, 2014 | 39 | 2014 |
| Fluoxetin upregulates connexin 43 expression in astrocyte H Mostafavi, M Khaksarian, MT Joghataei, G Hassanzadeh, M Soleimani, ... Basic and clinical neuroscience 5 (1), 74, 2014 | 33 | 2014 |
| Effect of bumetanide, a selective NKCC1 inhibitor, on hallucinations of schizophrenic patients; a double-blind randomized clinical trial. R Rahmanzadeh, S Eftekhari, A Shahbazi, M Khodaei Ardakani, ... Elsevier Science, 2017 | 32 | 2017 |
| Apelin-13 inhibits apoptosis of cortical neurons following brain ischemic reperfusion injury in a transient model of focal cerebral ischemia N Aboutaleb, H Kalalianmoghaddam, S Eftekhari, A Shahbazi, ... International Journal of Peptide Research and Therapeutics 20, 127-132, 2014 | 31 | 2014 |
| Pyramidal neuron growth and increased hippocampal volume during labor and birth in autism R Cloarec, B Riffault, A Dufour, H Rabiei, LA Gouty-Colomer, C Dumon, ... Science advances 5 (1), eaav0394, 2019 | 23 | 2019 |
| Selective β2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-Epac H Mostafavi, M Khaksarian, MT Joghataei, M Soleimani, G Hassanzadeh, ... Molecular Medicine Reports 9 (6), 2405-2410, 2014 | 17 | 2014 |
| Cell therapy in spinal cord injury: a mini-reivew S Mehrabi, S Eftekhari, F Moradi, H Delaviz, B Pourheidar, M Azizi, ... Basic and clinical neuroscience 4 (2), 172, 2013 | 14 | 2013 |
| Brain derived neurotrophic factor modification of epileptiform burst discharges in a temporal lobe epilepsy model S Eftekhari, S Mehrabi, F Karimzadeh, MT Joghataei, M Khaksarian, ... Basic and Clinical Neuroscience 7 (2), 115, 2016 | 13 | 2016 |
| Enhanced glutamatergic currents at birth in Shank3 KO Mice M Chiesa, R Nardou, N Lozovaya, S Eftekhari, R Tyzio, D Guimond, ... Neural plasticity 2019, 2019 | 5 | 2019 |
| Prenatal reduction of E14. 5 embryonically fate‐mapped pyramidal neurons in a mouse model of autism A Dufour, C Dumon, LA Gouty‐Colomer, S Eftekhari, DC Ferrari, ... European Journal of Neuroscience 56 (2), 3875-3888, 2022 | 3 | 2022 |
| The effect of tiagabine on physical development and neurological reflexes and their relationship with the γ-aminobutyric acid switch in the rat cerebral cortex during … A Shahrokhi, G Hassanzadeh, N Vousooghi, MT Joghataei, S Eftekhari, ... Behavioural Pharmacology 24 (7), 561-568, 2013 | 3 | 2013 |
| The early excitatory action of striatal cholinergic-GABAergic microcircuits conditions the subsequent GABA inhibitory shift N Lozovaya, S Eftekhari, C Hammond Communications Biology 6 (1), 723, 2023 | 1 | 2023 |
| UP-03.067 The Most Important Metabolic Risk Factors in Recurrent Urinary Stone Formers in Iran A Basiri, N Shakhssalim, M Parvin, A Miladipour, B Golestan, PM Torbati, ... Urology 78 (3), S364-S365, 2011 | 1 | 2011 |
Yehezkel Ben-AriNeurochlore, B&A Therapeutics, IBENDirección de correo verificada de neurochlore.fr
